Package 51991-054-05

Brand: oxcarbazepine

Generic: oxcarbazepine
NDC Package

Package Facts

Identity

Package NDC 51991-054-05
Digits Only 5199105405
Product NDC 51991-054
Product ID 51991-054_97572332-6115-49c3-af99-97744ce65352
Description

500 TABLET, FILM COATED in 1 BOTTLE (51991-054-05)

Marketing

Marketing Status
Marketed Since 2025-01-29
Brand oxcarbazepine
Generic oxcarbazepine
Sample Package No

Linked Drug Pages (1)

OXCARBAZEPINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "97572332-6115-49c3-af99-97744ce65352", "openfda": {"nui": ["N0000175753", "N0000008486"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["54fb494e-bce4-442d-954a-757f9851e81e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (51991-054-01)", "package_ndc": "51991-054-01", "marketing_start_date": "20250129"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (51991-054-05)", "package_ndc": "51991-054-05", "marketing_start_date": "20250129"}], "brand_name": "OXCARBAZEPINE", "product_id": "51991-054_97572332-6115-49c3-af99-97744ce65352", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51991-054", "generic_name": "OXCARBAZEPINE", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXCARBAZEPINE", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "300 mg/1"}], "application_number": "ANDA078069", "marketing_category": "ANDA", "marketing_start_date": "20080111", "listing_expiration_date": "20261231"}